Intelligent Asthma Monitoring Devices Market Size Is Anticipated To Reach A Valuation Of $654.96 Million By 2025

The global intelligent asthma monitoring market was valued at $20 million in 2017, and is projected to reach $655 million by 2025, growing at a CAGR of 54.5% from 2018 to 2025. Surge in prevalence of COPD and asthma and increase in adoption of smart inhalers are expected to propel the growth of the intelligent asthma monitoring devices market.

Increase in indoor air pollutants, rise in prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and surge in adoption of smart inhalers drive the growth of the global intelligent asthma monitoring devices market. However, concerns about data privacy hamper the market growth. On the contrary, increased focus toward advanced treatment protocols and unmet needs in respiratory care across developing countries are expected to create lucrative opportunities for the market players in the near future.

Download Sample https://www.alliedmarketresearch.com/request-sample/5124

Smart inhalers segment to be lucrative through 2025

Smart inhalers segment held the largest share in 2017, contributing more than four-fifths of the total market revenue. Moreover, the segment is expected to manifest the fastest CAGR of 57.0% during the forecast period because these devices are used for monitoring drug dose and improving drug administration time to identify asthma attack and avoid further complications. The other segment of wearable asthma is also analyzed in the report.

Home use segment to retain largest share through 2025

The home use segment is register the fastest CAGR of 53.8% from 2018 to 2025, as these products are user-friendly, help avoid severe attack due to real-time monitoring, and assist in drug dose and time of medication. However, hospitals segment held the largest share in 2017, contributing about two-fifths of total revenue, as it offers basic services for asthma monitoring along with availability of skilled nurses and trained professionals.

Asia-Pacific to grow the fastest through 2025

Asia-Pacific region is projected to grow at the fastest CAGR of 56.7% through 2025, owing to presence of high patient base, increase in healthcare expenditure by the populace, and technology advancements to launch cost-effective devices. However, North America held the largest share in 2017, contributing more than two-fifths of the total market revenue, owing to increased awareness about intelligent asthma monitoring devices among healthcare professionals & patients, availability of trained healthcare personnel, and high reimbursement policies. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).

Major market players

The key market players analyzed in the report include Vectura Group plc, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Qualcomm Life, Health Care Originals, GlaxoSmithKline plc, Propeller Health, Adherium Limited, AstraZeneca plc, Philips Healthcare, and Volansys Technologies.

Table Of Content

Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key Market Segments
1.3.1. List of key players profiled in the report:
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.5. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. key findings
3.2.1. Top investment pockets
3.3. Top player positioning
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Global Increase in air pollution
3.4.1.2. Increase in population susceptible to indoor air pollutants
3.4.1.3. Increasing prevalence of COPD and asthma globally
3.4.1.4. Expected increase in adherence to smart inhalers
3.4.1.5. Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers
3.4.1.6. Rising incidences of asthma cases
3.4.2. Restraints
3.4.2.1. Misusing data and data privacy
3.4.2.2. Resistance towards adoption of smart inhalers
3.4.3. Opportunities
3.4.3.1. Increased focus towards advanced treatment protocols
3.4.3.2. Significant unmet need in respiratory care
3.4.3.3. Opportunities in emerging economies
3.4.3.4. Impact analysis

Get More Information @ https://www.alliedmarketresearch.com/press-release/intelligent-asthma-monitoring-devices-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.